• Parkinson’s Research

  Non-invasive CDNF for Parkinson’s Being Developed, Herantis Announces

  Posted by Forum Moderator on July 16, 2018 at 8:12 am

  Herantis Pharma is launching a development program for non-invasive cerebral dopamine neurotrophic factor (CDNF) as a treatment candidate for patients with Parkinson’s disease.

  Read more about this: Herantis Announces New Program to Develop Non-Invasive CDNF for Parkinson’s Treatment

  What are your thoughts on this news?

  replied 5 years, 9 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply